Detalhe da pesquisa
1.
ALK-Fusion Transcripts Can Be Detected in Extracellular Vesicles (EVs) from Nonsmall Cell Lung Cancer Cell Lines and Patient Plasma: Toward EV-Based Noninvasive Testing.
Clin Chem
; 68(5): 668-679, 2022 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35348673
2.
A simple immunoassay for extracellular vesicle liquid biopsy in microliters of non-processed plasma.
J Nanobiotechnology
; 20(1): 72, 2022 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35135541
3.
ctDNA from body fluids is an adequate source for EGFR biomarker testing in advanced lung adenocarcinoma.
Clin Chem Lab Med
; 59(7): 1221-1229, 2021 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33691348
4.
Cancer as an infective disease: the role of EVs in tumorigenesis.
Mol Oncol
; 17(3): 390-406, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36168102
5.
Detecting ALK, ROS1, and RET fusions and the METΔex14 splicing variant in liquid biopsies of non-small-cell lung cancer patients using RNA-based techniques.
Mol Oncol
; 17(9): 1884-1897, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243883
6.
Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis.
Front Oncol
; 12: 943253, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35936733
7.
Molecular Divergence upon EGFR-TKI Resistance Could Be Dependent on the Exon Location of the Original EGFR-Sensitizing Mutation.
Cancers (Basel)
; 14(18)2022 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36139605
8.
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial).
J Clin Oncol
; 40(25): 2924-2933, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35576508
9.
R-Score: A New Parameter to Assess the Quality of Variants' Calls Assessed by NGS Using Liquid Biopsies.
Biology (Basel)
; 10(10)2021 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34681053
10.
NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment.
Mol Oncol
; 15(9): 2363-2376, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34058070
11.
Clinical utility of liquid biopsy for the diagnosis and monitoring of EML4-ALK NSCLC patients.
Adv Lab Med
; 1(1): 20190019, 2020 Mar.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-37362555
12.
Next-generation sequencing to dynamically detect mechanisms of resistance to ALK inhibitors in ALK-positive NSCLC patients: a case report.
Transl Lung Cancer Res
; 9(2): 366-372, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32420077
13.
ctDNA analysis reveals different molecular patterns upon disease progression in patients treated with osimertinib.
Transl Lung Cancer Res
; 9(3): 532-540, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676317
14.
Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation.
Cancer Epidemiol
; 67: 101737, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32450544
15.
Peritoneal washing is an adequate source for somatic BRCA1/2 mutation testing in ovarian malignancies.
Pathol Res Pract
; 215(2): 392-394, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30392916